Wise Young
02-25-2005, 09:37 PM
Financial Times and Scientific American to Publish Special Collaborative Report on Biotechnology and Stem Cell Research
NEW YORK - PRNewswire - Feb. 25
NEW YORK, Feb. 25 /PRNewswire/ -- The Financial Times and Scientific American will publish their first ever special collaborative report on June 20, 2005 entitled, "Biotechnology and Stem Cell Research". This specially targeted in-depth report will reach a combined circulation of over 800,000 across the US, Europe, and Asia, with additional distribution at the BIO 2005 Annual International Convention in Philadelphia.
The FT/Scientific American Biotechnology and Stem Cell Research report will focus on issues of public health, economics, ethics and the vast scientific ramifications of this extraordinary emerging science. Business executives, researchers and politicians alike will benefit from this discussion as each holds a unique stake in the course of future action. Uniquely respected by opinion leaders across the globe, both publications have come together to investigate both the promise and controversy surrounding biotechnology and stem cell research.
Not since the discovery of antibiotics has the scientific community been so excited about a new frontier. Stem cell research now has the potential to yield invaluable findings in the areas of cell and tissue regeneration and disease therapy. In addition, human stem cells may hold promise for testing new drugs and could yield information about the complexities of human development. Now with US and international collaboration, recognizing the potential and promise of stem cell research seems closer than ever. Source (http://interestalert.com/brand/siteia.shtml?Story=st/sn/02250000aaa063fc.prn&Sys=siteia&Fid=PUBLISHI&Type=News&Filter=Publishing)
NEW YORK - PRNewswire - Feb. 25
NEW YORK, Feb. 25 /PRNewswire/ -- The Financial Times and Scientific American will publish their first ever special collaborative report on June 20, 2005 entitled, "Biotechnology and Stem Cell Research". This specially targeted in-depth report will reach a combined circulation of over 800,000 across the US, Europe, and Asia, with additional distribution at the BIO 2005 Annual International Convention in Philadelphia.
The FT/Scientific American Biotechnology and Stem Cell Research report will focus on issues of public health, economics, ethics and the vast scientific ramifications of this extraordinary emerging science. Business executives, researchers and politicians alike will benefit from this discussion as each holds a unique stake in the course of future action. Uniquely respected by opinion leaders across the globe, both publications have come together to investigate both the promise and controversy surrounding biotechnology and stem cell research.
Not since the discovery of antibiotics has the scientific community been so excited about a new frontier. Stem cell research now has the potential to yield invaluable findings in the areas of cell and tissue regeneration and disease therapy. In addition, human stem cells may hold promise for testing new drugs and could yield information about the complexities of human development. Now with US and international collaboration, recognizing the potential and promise of stem cell research seems closer than ever. Source (http://interestalert.com/brand/siteia.shtml?Story=st/sn/02250000aaa063fc.prn&Sys=siteia&Fid=PUBLISHI&Type=News&Filter=Publishing)